Tucows Inc. Fumbles Q2 Earnings but Keeps Full-Year Targets Intact
The company fell far short of Wall Street's earnings consensus. To be fair, it was based on a single analyst's research and no official bottom-line guidance.
Thursday, August 9, 2018
Tucows Inc. Fumbles Q2 Earnings but Keeps Full-Year Targets Intact
Tucows Inc. Fumbles Q2 Earnings but Keeps Full-Year Targets Intact
The company fell far short of Wall Street's earnings consensus. To be fair, it was based on a single analyst's research and no official bottom-line guidance.
Related Posts:
AstraZeneca to buy Alexion for $39 billion to expand in immunology- How Pfizer delivered a COVID vaccine in record time: Crazy deadlines, a pushy CEO
- How Pfizer delivered a COVID vaccine in record time: Crazy deadlines, a pushy CEO
- US Supreme Court takes up Goldman securities class action appeal
- COVID-19 vaccine makers turn to testing children
0 comments:
Post a Comment